EP2121715A4 - Blocage de la migration ou de la metastase des cellules cancereuses par la modification de proteines d'adhesion et utilisations de nouveaux composes associes - Google Patents
Blocage de la migration ou de la metastase des cellules cancereuses par la modification de proteines d'adhesion et utilisations de nouveaux composes associesInfo
- Publication number
- EP2121715A4 EP2121715A4 EP08725693A EP08725693A EP2121715A4 EP 2121715 A4 EP2121715 A4 EP 2121715A4 EP 08725693 A EP08725693 A EP 08725693A EP 08725693 A EP08725693 A EP 08725693A EP 2121715 A4 EP2121715 A4 EP 2121715A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- metastasis
- migration
- blocking
- cancer cells
- new compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89038007P | 2007-02-16 | 2007-02-16 | |
US11/683,198 US8614197B2 (en) | 2003-10-09 | 2007-03-07 | Anti-tumor compounds with angeloyl groups |
US94770507P | 2007-07-03 | 2007-07-03 | |
PCT/US2007/077273 WO2008028060A2 (fr) | 2006-09-01 | 2007-08-30 | Composés antitumoraux servant à inhiber le développement du cancer |
PCT/US2008/002086 WO2008133766A1 (fr) | 2007-02-16 | 2008-02-15 | Blocage de la migration ou de la metastase des cellules cancereuses par la modification de proteines d'adhesion et utilisations de nouveaux composes associes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2121715A1 EP2121715A1 (fr) | 2009-11-25 |
EP2121715A4 true EP2121715A4 (fr) | 2010-12-29 |
Family
ID=39925959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08725693A Withdrawn EP2121715A4 (fr) | 2007-02-16 | 2008-02-15 | Blocage de la migration ou de la metastase des cellules cancereuses par la modification de proteines d'adhesion et utilisations de nouveaux composes associes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2121715A4 (fr) |
JP (1) | JP2010519219A (fr) |
CN (1) | CN101772511A (fr) |
AU (1) | AU2008244648A1 (fr) |
CA (1) | CA2676791A1 (fr) |
SG (1) | SG178795A1 (fr) |
WO (1) | WO2008133766A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727561B2 (en) | 2001-08-31 | 2010-06-01 | Pacific Arrow Limited | Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
US7524824B2 (en) | 2003-09-04 | 2009-04-28 | Pacific Arrow Limited | Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
US7488753B2 (en) | 2003-10-09 | 2009-02-10 | Pacific Arrow Limited | Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof |
US7514412B2 (en) | 2003-10-09 | 2009-04-07 | Pacific Arrow Limited | Anticancer biangeloyl saponins |
US8614197B2 (en) | 2003-10-09 | 2013-12-24 | Pacific Arrow Limited | Anti-tumor compounds with angeloyl groups |
US8586719B2 (en) | 2005-04-27 | 2013-11-19 | Pacific Arrow Limited | Triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents |
US20120277308A1 (en) | 2010-07-16 | 2012-11-01 | Pacific Arrow Limited | compounds for treating cancer and other diseases |
CN103391776B (zh) * | 2010-07-16 | 2023-11-28 | 太平洋艾瑞有限公司 | 可治疗癌症和其它疾病的新化合物 |
KR101398079B1 (ko) * | 2011-10-10 | 2014-05-27 | 재단법인 의약바이오컨버젼스연구단 | 글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법 |
KR101403019B1 (ko) | 2013-02-25 | 2014-06-03 | 서울대학교산학협력단 | 폐암 진단용 마커 |
CN105431548A (zh) * | 2013-03-15 | 2016-03-23 | 生物医学研究机构基金会 | 用于癌转移的诊断、预后和治疗的方法 |
CN103235141A (zh) * | 2013-04-27 | 2013-08-07 | 上海交通大学医学院附属新华医院 | Atf3用于预测膀胱癌转移和判断预后的应用 |
JP6339814B2 (ja) * | 2014-02-05 | 2018-06-06 | 株式会社島津製作所 | がん転移マーカー及びその分析方法 |
CN104502603B (zh) * | 2014-12-03 | 2016-04-06 | 上海交通大学医学院附属上海儿童医学中心 | Myo1d作为诊断动脉导管闭合或开放的标志物 |
JP2017538412A (ja) | 2014-12-11 | 2017-12-28 | インバイオモーション エセ.エレ. | ヒトc−mafに対する結合メンバー |
CN105061545B (zh) * | 2015-08-17 | 2018-01-30 | 中国人民解放军第二一〇医院 | 文冠果中三萜皂苷类化合物及其制备方法和应用 |
US10167293B2 (en) * | 2016-05-26 | 2019-01-01 | Bayer Pharma Aktiengesellschaft | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones |
CN106947821B (zh) * | 2017-04-11 | 2020-06-30 | 成都望路医药技术有限公司 | 用于诊治结肠腺癌的生物标志物 |
CN108410986B (zh) * | 2018-02-26 | 2021-06-22 | 中国人民解放军总医院 | Cdh6促进骨肉瘤生长和转移 |
CN110272997B (zh) * | 2018-03-14 | 2023-04-28 | 华中科技大学同济医学院附属同济医院 | 一种C/EBPβ基因或者蛋白的用途 |
KR102128331B1 (ko) * | 2018-04-30 | 2020-06-30 | 인하대학교 산학협력단 | Cdh13 또는 이를 코딩하는 유전자의 발현을 억제하는 제제를 포함하는, 방사선 치료로 인하여 노화된 혈관내피세포로 전이가 발생하는 암 전이 억제용 조성물 |
CN109970839B (zh) * | 2019-04-16 | 2022-03-01 | 沈阳药科大学 | 三萜皂苷类化合物及其制备方法和医药用途 |
CN110672848A (zh) * | 2019-10-25 | 2020-01-10 | 四川大学华西医院 | Apeh自身抗体检测试剂在制备肺癌筛查试剂盒中的用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037200A2 (fr) * | 2003-10-09 | 2005-04-28 | Pacific Arrow Limited | Composition comprenant des extraits de xanthoceras sorbifolia, composes isoles a partir de ces derniers, procedes de preparation et utilisations de ces derniers |
WO2005063273A1 (fr) * | 2003-12-23 | 2005-07-14 | Pacific Arrow Limited | Composition comprenant des extraits de xanthoceras sorbifolia, composes isoles a partir ce celle-ci, methodes de preparation associees et utilisations de ceux-ci |
WO2006029221A2 (fr) * | 2004-09-07 | 2006-03-16 | Pacific Arrow Limited | Composes antitumoraux comprenant des groupes angeloyl |
WO2006116656A2 (fr) * | 2005-04-27 | 2006-11-02 | Pacific Arrow Limited | Composition contenant des saponines triterpeniques et des composes a groupes fonctionnels angeloyle destinee a inhiber l'insuffisance veineuse, le gonflement des jambes et les tumeurs |
WO2008028060A2 (fr) * | 2006-09-01 | 2008-03-06 | Pacific Arrow Limited | Composés antitumoraux servant à inhiber le développement du cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6616943B2 (en) * | 2001-08-31 | 2003-09-09 | Fountain Silver Limited | Composition comprising Wenguanguo extracts and methods for preparing same |
-
2008
- 2008-02-15 JP JP2009550096A patent/JP2010519219A/ja active Pending
- 2008-02-15 WO PCT/US2008/002086 patent/WO2008133766A1/fr active Application Filing
- 2008-02-15 EP EP08725693A patent/EP2121715A4/fr not_active Withdrawn
- 2008-02-15 SG SG2012011029A patent/SG178795A1/en unknown
- 2008-02-15 CN CN200880012065A patent/CN101772511A/zh active Pending
- 2008-02-15 AU AU2008244648A patent/AU2008244648A1/en not_active Abandoned
- 2008-02-15 CA CA002676791A patent/CA2676791A1/fr not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037200A2 (fr) * | 2003-10-09 | 2005-04-28 | Pacific Arrow Limited | Composition comprenant des extraits de xanthoceras sorbifolia, composes isoles a partir de ces derniers, procedes de preparation et utilisations de ces derniers |
WO2005063273A1 (fr) * | 2003-12-23 | 2005-07-14 | Pacific Arrow Limited | Composition comprenant des extraits de xanthoceras sorbifolia, composes isoles a partir ce celle-ci, methodes de preparation associees et utilisations de ceux-ci |
WO2006029221A2 (fr) * | 2004-09-07 | 2006-03-16 | Pacific Arrow Limited | Composes antitumoraux comprenant des groupes angeloyl |
WO2006116656A2 (fr) * | 2005-04-27 | 2006-11-02 | Pacific Arrow Limited | Composition contenant des saponines triterpeniques et des composes a groupes fonctionnels angeloyle destinee a inhiber l'insuffisance veineuse, le gonflement des jambes et les tumeurs |
WO2008028060A2 (fr) * | 2006-09-01 | 2008-03-06 | Pacific Arrow Limited | Composés antitumoraux servant à inhiber le développement du cancer |
Non-Patent Citations (10)
Title |
---|
AHN KYUNG-SEOP ET AL: "Effects of oleanane-type triterpenoids from fabaceous plants on the expression of ICAM-1", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. 25, no. 8, August 2002 (2002-08-01), pages 1105 - 1107, XP002609400, ISSN: 0918-6158 * |
CHEMICAL AND PHARMACEUTICAL BULLETIN (TOKYO), vol. 48, no. 11, November 2000 (2000-11-01), pages 1711 - 1719, ISSN: 0009-2363 * |
CHINESE JOURNAL OF LUNG CANCER 200308 CN, vol. 6, no. 4, August 2003 (2003-08-01), pages 254 - 257, ISSN: 1009-3419 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2004, OVESNA Z ET AL: "Pentacyclic triterpenoic acids: new chemoprotective compounds", XP002609502, Database accession no. PREV200500050812 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; November 2000 (2000-11-01), TEZUKA YASUHIRO ET AL: "Constituents of the Vietnamese medicinal plant Orthosiphon stamineus", XP002609401, Database accession no. PREV200100067220 * |
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; August 2003 (2003-08-01), HUANG W ET AL: "Study on anti-invasive effect and apoptosis induction of pentacyclic triterpenoid in human lung cancer cells", XP002609399, Database accession no. EMB-2003347021 * |
KONOSHIMA T ET AL: "ANTITUMOR AGENTS 82. CYTOTOXIC SAPOGENOLS FROM AESCULUS-HIPPOCASTANUM", JOURNAL OF NATURAL PRODUCTS, AMERICAN CHEMICAL SOCIETY, US, vol. 49, no. 4, 1 July 1986 (1986-07-01), pages 650 - 656, XP002510554, ISSN: 0163-3864, DOI: 10.1021/NP50046A015 * |
NEOPLASMA (BRATISLAVA), vol. 51, no. 5, 2004, pages 327 - 333, ISSN: 0028-2685 * |
See also references of WO2008133766A1 * |
VOUTQUENNE L ET AL: "Haemolytic acylated triterpenoid saponins from Harpullia austro-caledonica", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 66, no. 7, 1 April 2005 (2005-04-01), pages 825 - 835, XP004846755, ISSN: 0031-9422, DOI: 10.1016/J.PHYTOCHEM.2005.02.009 * |
Also Published As
Publication number | Publication date |
---|---|
SG178795A1 (en) | 2012-03-29 |
AU2008244648A1 (en) | 2008-11-06 |
JP2010519219A (ja) | 2010-06-03 |
WO2008133766A1 (fr) | 2008-11-06 |
EP2121715A1 (fr) | 2009-11-25 |
CN101772511A (zh) | 2010-07-07 |
CA2676791A1 (fr) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2121715A4 (fr) | Blocage de la migration ou de la metastase des cellules cancereuses par la modification de proteines d'adhesion et utilisations de nouveaux composes associes | |
EP2254899A4 (fr) | Blocage des métastases de cellules cancéreuses et nouvelles compositions à cet effet | |
EP2436696B8 (fr) | Anticorps anti-amyloide et son utilisation | |
IL200012A0 (en) | Anti-robo4 antibodies and uses therefor | |
IL218776A0 (en) | Modified factor vii polypeptides and uses thereof | |
EP2223969A4 (fr) | Composition de résine, élément transparent obtenu à partir de ladite composition de résine et son utilisation | |
HK1142341A1 (en) | Anti-hepcidin antibodies and uses thereof | |
DE602008005212D1 (de) | Metallisches, doppelseitiges Element und Reißverschluss | |
EP2195024A4 (fr) | Procédé d'inhibition d'activation de complément avec des anticorps spécifique de facteur bb | |
HK1168843A1 (zh) | 取代的喹喔啉型呱啶化合物及其用途 | |
HK1144556A1 (en) | Inhibition of tumor metastasis by anti-neuropilin antibodies | |
EP2116574A4 (fr) | Composition contenant un composé pyrimidine et élément luminescent utilisant la composition | |
SE0601195L (sv) | Sätt att tillverka agglomererade hårdmetall- eller cermetpulverblandningar | |
EP2241613A4 (fr) | Cartouche réceptrice de fluide et son utilisation | |
IL203000A (en) | Coating of hard material of al – ti – ru – n – c | |
EP2128249A4 (fr) | Anticorps de fixation à l'oxyde de zinc et son utilisation | |
HK1121588A1 (en) | Improved seal assembly for battery and the battery using the same | |
AU2009213453A8 (en) | Anti-ADAM-15 antibodies and utilization of the same | |
FR2922950B1 (fr) | Cartouche de materiau abradable | |
EP2184793A4 (fr) | Elément de commutation et son application | |
GB0701728D0 (en) | Assays and therapy | |
EP2155970B8 (fr) | Vanne de vidange | |
DE502006007999D1 (de) | Dichtungsstrang mit Beschichtung | |
IL205405A0 (en) | Polypeptide compound, composition comprising the same and use thereof | |
AU2007903494A0 (en) | Modulation of Pericyte Migration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090913 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MAK, MAY, SUNG Inventor name: CHAN, PUI-KWONG |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1136301 Country of ref document: HK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 35/00 20060101ALI20101117BHEP Ipc: A61K 31/704 20060101AFI20101117BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20101126 |
|
17Q | First examination report despatched |
Effective date: 20131018 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140301 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1136301 Country of ref document: HK |